If this keeps up much longer, there will be more eyes on NatureWell Inc. (OTCBB: NAWL) than there will be on the SuperBowl next weekend.

Running up a whopping 287.5% in trading today on news that its aggressive marketing plan is ramping up in a major way, NAWL attracted so many investor inquiries today that we had to bring on auxiliary staff.

Today’s run should be very interesting to readers. First of all for the gains that could have been made for an investment of a few thousand dollars. Secondly, and more importantly for the fact that the company's MigraSpray, product has been proven extremely effective in scientific studies and is now positioned to tap into both the $1.5 billion dollar market for migraine remedies and the potential "untapped" $3.5 billion market for migraines prevention.

It all starts with NAWL’s aggressive growth strategy that has taken its next big step today. At this point in time, NAWL is emerging as one of the best prospects at its price. If wide-scale sample testing amongst the company’s key target market proves to be successful, the implications for share price are extremely positive.

Growth such as that exhibited today though is obviously impossible to replicate on a daily basis. However, if NAWL is somehow able to pull a few strings and become the treatment of choice for the country’s 32 million migraine sufferers, the possibilities are virtually endless. This is indeed food for thought at a fraction of a penny. Don’t you think?

Labels: Big Gainers, Daily Runners, Micro Cap Stocks, Migraine, Migraine Headache, Naturewell, Naturewell Inc., NAWL, OTCBB:NAWL, Penny Stocks, Small Cap Stocks